Cerebras Systems Inc. (NASDAQ: CBRS) and IREN Ltd. (NASDAQ: IREN) recorded significant share price appreciation over the past five trading sessions, climbing 9.55% and 15.90% respectively. The parallel movement in these stocks is linked to their inclusion in the portfolio of Situational Awareness LP, a hedge fund managed by Leopold Aschenbrenner that focuses on physical infrastructure supporting artificial intelligence.

The fund’s Q2 13F filing, reported as of June 30, revealed a public equity portfolio valued at $20.24 billion. Within this portfolio, Situational Awareness held 9.5 million shares of IREN, valued at $433.25 million. The filing also disclosed a newly initiated stake of 10,000 shares in Cerebras Systems, valued at $2.21 million.

What the Numbers Show

A divergence exists between the fund’s share count adjustments and the resulting portfolio value changes for IREN. While the number of IREN shares held by Situational Awareness decreased by 19% from Q1 to Q2 (falling from 11,698,835 to 9,474,099), the total value of the holding increased by 8% (rising from $401,036,000 to $433,250,000). This indicates that the stock price appreciation outpaced the reduction in share count during the period.

For Cerebras Systems, the fund established a new position of 10,000 shares in Q2, up from zero in Q1, representing a new investment of $2,210,000.

Operational Catalysts

Recent stock performance was also driven by specific operational announcements. On August 13, IREN announced the successful delivery and acceptance of "Horizon 1," a 50MW direct-to-chip liquid-cooled AI cloud deployment for Microsoft Corp. (NASDAQ: MSFT). This milestone is part of a five-year, $9.7 billion contract between the two companies. Additionally, IREN achieved "NVIDIA Exemplar Cloud status" on NVIDIA GB300 NVL72 following site testing.

Simultaneously, Cerebras announced it is powering "Ultrafast," a new API tier for OpenAI’s GPT-5.6 Sol model, which runs up to 14x faster than standard processing. OpenAI has committed to utilizing 750MW of Cerebras capacity through 2028.

Performance Overview

Both stocks have shown strong momentum over various timeframes. IREN shares are up 128.03% over the past year and 18.88% year-to-date. Cerebras, which was listed on May 14, 2026, is down 28.01% since listing but has gained 45.77% over the past month.

Despite a severe market contraction in July that led to high-leverage margin unwinds and the acquisition of Situational Awareness’s equity positions by Citadel LLC, the thesis around owning physical AI compute and power assets continues to drive independent momentum in these names.

Cerebras Systems Inc. (NASDAQ: CBRS) shares surged 15.88% to $253.76 in Monday morning trading, marking a sharp recovery from the 18.63% decline seen in premarket trading following its second-quarter 2026 earnings report. The rally was driven by a wave of institutional position disclosures filed after Friday’s close, alongside renewed investor confidence in management’s upbeat 2027 demand commentary and raised fiscal 2026 outlook.

Institutional Accumulation

The price action reflects significant interest from prominent hedge funds building sizable stakes during the second quarter. Chase Coleman’s Tiger Global Management disclosed a massive new position of nearly 3.0 million shares valued at $663 million, marking one of the firm’s largest new technology bets. Ken Griffin’s Citadel Advisors revealed a 1.25 million-share stake accompanied by extensive call option holdings. Altimeter Capital and Atreides Management also reported significant equity positions.

Additionally, Cathie Wood’s ARK Invest bought 106,941 shares (valued at roughly $28 million) across its ARKK and ARKW ETFs on August 13, stepping in to purchase the post-earnings selloff directly. Even with Monday’s bounce, the stock is navigating key technical levels, trading above its 20-day moving average of $224.50 while attempting to reclaim previous ranges. Shares have gained nearly 50% over the trailing month.

Analyst Upgrades and OpenAI Partnership

Wedbush analyst Matt Bryson raised his price target on Cerebras from $280 to $290, maintaining an Outperform rating. Bryson highlighted the launch of “Ultrafast,” a new API service tier for OpenAI’s GPT-5.6 Sol model, which runs at up to 750 output tokens per second—speeds up to 14 times faster than standard processing. He noted that OpenAI remains committed to taking 750 MW of Cerebras capacity by 2028, with contract options allowing for additional capacity through 2030.

Neo-Cloud Diversification and Guidance

The rally serves as a sentiment reset after the stock fell last week despite posting record core revenue of $209.9 million, up 103% year-over-year. The initial pressure stemmed from GAAP revenue of $180.11 million missing the Street estimate of $194.2 million by 7.26%. CEO Andrew Feldman framed this as a temporary swing rather than a structural bottleneck, emphasizing that emerging neo-cloud providers are diversifying away from single-vendor GPU dependence on NVIDIA Corporation (NASDAQ: NVDA).

Management raised its full-year 2026 core revenue guidance to $880 million to $890 million, with gross margins expected between 41% and 43%. Feldman described the shift toward multi-vendor stacks or Advanced Micro Devices, Inc. (NASDAQ: AMD) hardware as creating “large” opportunities for Cerebras in 2027. The company’s remaining performance obligations stand at $25.4 billion, providing substantial revenue visibility as capacity expands.

What the Numbers Show

The divergence between the initial sell-off and the subsequent institutional buying underscores a market reassessment of Cerebras’ growth trajectory. While GAAP metrics missed due to non-cash adjustments (including $44.3 million in amortization of customer warrant assets), core fundamentals strengthened significantly. Core gross margin expanded to 40.6%, an improvement of approximately 940 basis points year-over-year. The combination of a robust balance sheet—featuring $8.6 billion in cash and equivalents—and a $25.4 billion backlog suggests that the recent volatility was driven by short-term accounting nuances rather than underlying business health.